Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 3 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

Enrollment Performance

Analytics

No phase data available

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (3)

Showing 3 of 3 trials
NCT02001038Completed

Survey of Current Management of Orthopaedic Complications in CMT Patients

Role: collaborator

NCT02190929Completed

Educational Needs of Patients With Systemic Vasculitis

Role: collaborator

NCT02176070Completed

Reproductive Health in Men and Women With Vasculitis

Role: collaborator

All 3 trials loaded